Caristo Diagnostics
Measures coronary inflammation from CT scans to predict future cardiovascular events.
What they do
Develops advanced coronary imaging software that identifies vascular inflammation from routine CT scans. The technology generates a cardiovascular risk score, enabling preventive therapy decisions for patients who otherwise show no signs of coronary narrowing.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Cardiovascular imaging AI
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
- Founded
- 2018
- Total funding
- $40M raised
Notable investors: Oxford Science Enterprises, BGF, Longwall Venture Partners.